CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Clinical trial NCT04145349 · COMPLETED
Trial details
- NCT number
- NCT04145349
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2024-06-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.